On March 30th 2012, at the invitation of Prof. Weiliang Zhu, Dr. Phil Goliber from UCB Pharma visited Shanghai Institute of Materia Medica for academic exchanges and delivered an academic lecture with the title of  “Questions, Directions and Opportunities for Pharma Collaborations in China - How to Choose?”.After the lecture, Dr. Phil Goliber visited Chinese National Compounds Library of SIMM and discussed the potential collaboration withProf. Hualiang JIANG, Prof. Yang YE, and Prof. Weiliang ZHU

UCB is a bio-pharmaceutical company headquartered in Belgium with over 8500 employees worldwide and about $4.5 billion in revenue. Prior to his current role, Dr. Goliber built the Pharmaceutical Sciences Department in UCB and served as Vice President, and worked on the subsequent integration of Biopharma Process Sciences.